Matthew A. Naylor

1.5k total citations
53 papers, 1.1k citations indexed

About

Matthew A. Naylor is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Matthew A. Naylor has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 16 papers in Molecular Biology and 9 papers in Toxicology. Recurrent topics in Matthew A. Naylor's work include Synthesis and Biological Evaluation (11 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Matthew A. Naylor is often cited by papers focused on Synthesis and Biological Evaluation (11 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Matthew A. Naylor collaborates with scholars based in United Kingdom, South Africa and United States. Matthew A. Naylor's co-authors include Ian J. Stratford, Michael R.L. Stratford, Steven A. Everett, Peter Wardman, John Nolan, G.E. Adams, Peter D. Davis, Sally A. Hill, Mohammed Jaffar and E.M. Fielden and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and British Journal of Cancer.

In The Last Decade

Matthew A. Naylor

53 papers receiving 1.0k citations

Peers

Matthew A. Naylor
William A. Denny New Zealand
Moana Tercel New Zealand
Susan M. Pullen New Zealand
G. M. Tozer United Kingdom
Krishnamurthy Shyam United States
Renukadevi Patil United States
William A. Denny New Zealand
Matthew A. Naylor
Citations per year, relative to Matthew A. Naylor Matthew A. Naylor (= 1×) peers William A. Denny

Countries citing papers authored by Matthew A. Naylor

Since Specialization
Citations

This map shows the geographic impact of Matthew A. Naylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Naylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Naylor more than expected).

Fields of papers citing papers by Matthew A. Naylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Naylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Naylor. The network helps show where Matthew A. Naylor may publish in the future.

Co-authorship network of co-authors of Matthew A. Naylor

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Naylor. A scholar is included among the top collaborators of Matthew A. Naylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Naylor. Matthew A. Naylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menanteau‐Ledouble, Simon, et al.. (2022). Gonad development in farmed male and female South African abalone, Haliotis midae, fed artificial and natural diets under a range of husbandry conditions. Aquaculture International. 30(3). 1279–1293. 3 indexed citations
2.
Kaiser, Horst, et al.. (2013). The effects of competitor density on aggressive behaviour and resource defence in a Poeciliid fish. Journal of Applied Ichthyology. 29(6). 1264–1268. 3 indexed citations
3.
Thomson, Peter, Matthew A. Naylor, Michael R.L. Stratford, et al.. (2007). Hypoxia-driven elimination of thiopurines from their nitrobenzyl prodrugs. Bioorganic & Medicinal Chemistry Letters. 17(15). 4320–4322. 15 indexed citations
4.
Davis, Peter D., Graeme J. Dougherty, David C. Blakey, et al.. (2002). ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.. Oxford University Research Archive (ORA) (University of Oxford). 62(24). 7247–53. 200 indexed citations
5.
Davis, Peter D., Gillian M. Tozer, Matthew A. Naylor, et al.. (2002). Enhancement of vascular targeting by inhibitors of nitric oxide synthase. International Journal of Radiation Oncology*Biology*Physics. 54(5). 1532–1536. 12 indexed citations
6.
Naylor, Matthew A., et al.. (2001). Recent Advances in Bioreductive Drug Targeting. Mini-Reviews in Medicinal Chemistry. 1(1). 17–29. 29 indexed citations
7.
Janes, Robert W., B.S. Potter, Matthew A. Naylor, et al.. (2001). 1-Methylindole-3-carboxaldehyde oxime derivatives. Acta Crystallographica Section C Crystal Structure Communications. 57(1). 58–61. 1 indexed citations
9.
Everett, Steven A., Matthew A. Naylor, Stephen Moore, et al.. (1999). Prodrugs for targeting hypoxic tissues: Regiospecific elimination of aspirin from reduced indolequinones. Bioorganic & Medicinal Chemistry Letters. 9(1). 113–118. 20 indexed citations
11.
Everett, Steven A., Matthew A. Naylor, K B Patel, M.R.L. Stratford, & Peter Wardman. (1999). Bioreductively-activated prodrugs for targeting hypoxic tissues: Elimination of aspirin from 2-nitroimidazole derivatives. Bioorganic & Medicinal Chemistry Letters. 9(9). 1267–1272. 28 indexed citations
12.
Naylor, Matthew A., et al.. (1996). Structural Requirements for EO9 Toxicity and Dependence on P450 Reductase for Activation. British Journal of Cancer. 2 indexed citations
13.
Naylor, Matthew A., G.E. Adams, Soren Cole, et al.. (1995). Fused pyrazine mono-N-oxides as bioreductive drugs III. Characterization of RB 90740 in vitro and in vivo. Anti-Cancer Drugs. 6(2). 259–269. 11 indexed citations
14.
Naylor, Matthew A., et al.. (1994). Pharmacokinetics, metabolism and distribution of 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-al pyrido [3,2-el pyrazine-5-oxide in C3H mice. International Journal of Radiation Oncology*Biology*Physics. 29(2). 339–344. 4 indexed citations
15.
Adams, G.E., et al.. (1994). Comparing the anti-tumor effect of several bioreductive drugs when used in combination with photodynamic therapy (PDT). International Journal of Radiation Oncology*Biology*Physics. 29(2). 329–332. 6 indexed citations
16.
Naylor, Matthew A., John Nolan, Peter O’Neill, et al.. (1994). Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicity. International Journal of Radiation Oncology*Biology*Physics. 29(2). 333–337. 6 indexed citations
17.
Naylor, Matthew A., Michael D. Threadgill, Paul B. Webb, et al.. (1992). 2-Nitroimidazole dual-function bioreductive drugs: studies on the effects of regioisomerism and side-chain structural modifications on differential cytotoxicity and radiosensitization by aziridinyl and oxiranyl derivatives. Journal of Medicinal Chemistry. 35(19). 3573–3578. 14 indexed citations
18.
Threadgill, Michael D., Paul B. Webb, P. O’Neill, et al.. (1991). Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins. Journal of Medicinal Chemistry. 34(7). 2112–2120. 20 indexed citations
19.
Naylor, Matthew A., Miriam A. Stephens, Soren Cole, et al.. (1990). Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins. Journal of Medicinal Chemistry. 33(9). 2508–2513. 19 indexed citations
20.
Naylor, Matthew A., et al.. (1953). Extensions of the Willgerodt Reaction. I. Journal of the American Chemical Society. 75(21). 5392–5394. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026